3 stories from 2 sources
Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.
A curated list of other prominent stories from this day.
The American College of Obstetricians and Gynecologists released a pregnancy vaccine schedule that differs from the CDC’s guidance. The recommendations aim to guide obstetric care teams on which vaccines to prioritize and when during pregnancy.
10:44 AMStat NewsRepublican-led federal actions and policy proposals are reviving scrutiny of methadone and buprenorphine, two core medications for opioid use disorder. Addiction clinicians and patient advocates warn the shift could restrict access and increase overdose risk.
4:30 AMStat NewsA large study links glucosamine use to faster progression from mild cognitive impairment to Alzheimer’s disease. Users showed about a 25% higher likelihood of developing dementia, alongside biological signals that could explain the association.
1:17 AMScienceDailySummary
The American College of Obstetricians and Gynecologists released a pregnancy vaccine schedule that differs from the CDC’s guidance. The recommendations aim to guide obstetric care teams on which vaccines to prioritize and when during pregnancy.
Why it matters
A split between ACOG and CDC can reshape prenatal vaccination uptake and create operational and reimbursement ambiguity for maternity care.
Summary
Republican-led federal actions and policy proposals are reviving scrutiny of methadone and buprenorphine, two core medications for opioid use disorder. Addiction clinicians and patient advocates warn the shift could restrict access and increase overdose risk.
Why it matters
Any rollback in MOUD access would likely translate quickly into higher overdose deaths and greater strain on emergency care, jails, and public health budgets.
Summary
A large study links glucosamine use to faster progression from mild cognitive impairment to Alzheimer’s disease. Users showed about a 25% higher likelihood of developing dementia, alongside biological signals that could explain the association.
Why it matters
If the link holds, a widely used supplement could be accelerating dementia in the exact population most likely to take it.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!